See development and validation data for our 40‑plex cytokine immunoassay panel, which includes biomarkers for cancer, inflammatory responses, and infectious disease.
Download the brochure to see how Clarity and Clarity Max™ Substrates meet all western blotting needs.
See how the S3e™ Cell Sorter allows sorting of single cells.
Detection of 18 phosphoproteins in tissue lysates using the Bio-Plex®® Suspension Array System.
Simultaneous quantitation of nine biomarkers in sera from cancer patients using the Bio-Plex System.
Analysis of EGFR signaling in patient-derived tumor xenografts using the Bio-Plex Suspension Array System.
Detection of EGFR and Bcr-Abl drug resistance mutations in cancer cells using the Bio-Plex System.
Design and validation of triplex one-step RT-qPCR assays for the detection of colorectal cancer biomarkers.
Cancer proteome profiling using 2-D PAGE to identify biomarkers of bladder squamous cell carcinoma progression.
Droplet Digital™ PCR (ddPCR™) detects actionable KRAS mutations in FFPE samples present at <1%.
Measuring potential disease-biomarkers in breast cancer tissue homogenates using Bio-Plex Pro™ Assays.
ddPCR detects actionable KRAS mutations in cell-free DNA and FFPE samples with limit of detection of 0.2%.
Identification of tumor models and biomarkers for drug response or resistance using the Bio-Plex Suspension Array System.
Validation study for multiplex analysis of rat cytokines and diabetes biomarkers using Bio-Plex Pro Assays.
Ideal for FFPE and liquid biopsy samples, fresh/frozen tissue, and samples with low yield or inhibitory substances.
Selecting the optimal resins for removal of DNA contamination during process purification.
Save time, identify problems earlier, and have more confidence in your western blot results.
See how biomarkers can increase the likelihood of clinical trial success.
Listen to the co-founder and CSO of Amplion, Inc discuss why biomarkers are critical to clinical trial success.